Recombinant multi-species TRAF2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TRAF2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins associate with, and mediate the signal transduction from members of the TNF receptor superfamily. This protein directly interacts with TNF receptors, and forms a heterodimeric complex with TRAF1. This protein is required for TNF-alpha-mediated activation of MAPK8/JNK and NF-kappaB. The protein complex formed by this protein and TRAF1 interacts with the inhibitor-of-apoptosis proteins (IAPs), and functions as a mediator of the anti-apoptotic signals from TNF receptors. The interaction of this protein with TRADD, a TNF receptor associated apoptotic signal transducer, ensures the recruitment of IAPs for the direct inhibition of caspase activation. BIRC2/c-IAP1, an apoptosis inhibitor possessing ubiquitin ligase activity, can unbiquitinate and induce the degradation of this protein, and thus potentiate TNF-induced apoptosis. Multiple alternatively spliced transcript variants have been found for this gene, but the biological validity of only one transcript has been determined. [provided by RefSeq, Jul 2008]
The Alternative Names of target: E3 ubiquitin-protein ligase TRAF2,MGC:45012,RING-type E3 ubiquitin transferase TRAF2,RNF117,TNF receptor-associated factor 2,TRAF2,TRAP,TRAP3,Traf2,Tumor necrosis factor type 2 receptor-associated protein 3
Go
to TRAF2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP11724-Ag-1/ GM-Tg-hg-IP11724-Ag-2 | Human TRAF2 protein | Human |
| GM-Tg-rg-IP11724-Ag-1/ GM-Tg-rg-IP11724-Ag-2 | Rat TRAF2 protein | Rat |
| GM-Tg-mg-IP11724-Ag-1/ GM-Tg-mg-IP11724-Ag-2 | Mouse TRAF2 protein | Mouse |
| GM-Tg-cynog-IP11724-Ag-1/ GM-Tg-cynog-IP11724-Ag-2 | Cynomolgus/Rhesus macaque TRAF2 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP11724-Ag-1/ GM-Tg-felg-IP11724-Ag-2 | Feline TRAF2 protein | Feline |
| GM-Tg-cang-IP11724-Ag-1/ GM-Tg-cang-IP11724-Ag-2 | Canine TRAF2 protein | Canine |
| GM-Tg-bovg-IP11724-Ag-1/ GM-Tg-bovg-IP11724-Ag-2 | Bovine TRAF2 protein | Bovine |
| GM-Tg-equg-IP11724-Ag-1/ GM-Tg-equg-IP11724-Ag-2 | Equine TRAF2 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP11724-Ag-1/ GM-Tg-hg-IP11724-Ag-2;
GM-Tg-rg-IP11724-Ag-1/ GM-Tg-rg-IP11724-Ag-2;
GM-Tg-mg-IP11724-Ag-1/ GM-Tg-mg-IP11724-Ag-2; GM-Tg-cynog-IP11724-Ag-1/ GM-Tg-cynog-IP11724-Ag-2; GM-Tg-felg-IP11724-Ag-1/ GM-Tg-felg-IP11724-Ag-2; GM-Tg-cang-IP11724-Ag-1/ GM-Tg-cang-IP11724-Ag-2; GM-Tg-bovg-IP11724-Ag-1/ GM-Tg-bovg-IP11724-Ag-2; GM-Tg-equg-IP11724-Ag-1/ GM-Tg-equg-IP11724-Ag-2 |
| Products Name | TRAF2 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | TRAF2 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TRAF2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.